TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Oct 13, 2026, 4:00 PM EDT
1.770
+0.090 (5.36%)
After-hours: Oct 13, 2026, 7:46 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $28.44 million as of October 13, 2026. It is the 34,702nd most valuable company in the world and the 5,060th biggest in the United States. Its market cap has increased by 119.22% in one year.
Market Cap
28.44M
Enterprise Value
20.71M
1-Year Change
119.22%
Global Rank
Country Rank
#5,060 United States
Category
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $28.44M, a decrease of -40.58%. That is a compound annual growth rate of -9.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 28.44M | 354.16% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 36.31M |
| GridAI Technologies | 35.19M |
| Actinium Pharmaceuticals | 34.59M |
| BriaCell Therapeutics | 34.21M |
| CEL-SCI | 34.12M |
| Aligos Therapeutics | 33.35M |
| NanoViricides | 33.18M |
| NextCure | 32.87M |